| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $5.76M | $6.34M | $15.49M | $23.12M | $13.97M |
| SG&A | $6.73M | $4.31M | $7.43M | $7.83M | $4.64M |
| Operating Income | -$12.64M | -$11.29M | -$22.92M | -$30.95M | -$28.36M |
| Interest Expense | -$110.00K | -$93.00K | -$28.00K | – | $2.43M |
| Tax Expense | – | – | – | – | – |
| Net Income | -$12.49M | -$10.78M | -$22.46M | -$27.99M | -$30.21M |
| EPS (basic) | -2.9300 | -2.8600 | -0.6500 | -0.8300 | -1.1600 |
| EPS (diluted) | -2.9300 | -2.8600 | -0.6500 | -0.8300 | -1.1600 |
| Shares (diluted) | $4.27M | $3.77M | $34.36M | $33.67M | $26.03M |